InOncology

Founded in 1885, Boehringer Ingelheim is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim am Rhein, Germany, Boehringer Ingelheim is a family-owned, globally operating research-driven group of companies committed to the goal of serving mankind through research into diseases and the development of new treatment opti... ons of high therapeutic value for human and veterinary medicine. The Boehringer Ingelheim group, with 142 affiliates in 50 countries across the world and more than 41,500 employees, reported net sales of €12.7 billion in 2009, while spending 21% of net sales in its largest business segment Prescription Medicines on research and development. Leaders in the area of respiratory medicine, with its chronic obstructive pulmonary disease (COPD) treatment Spiriva ®, Boehringer Ingelheim is also making significant contributions to research in cardiometabolic, CNS, neurological and immunology/infectious diseases.Read More